AMZN
Amazon.com, Inc.
AMZN has the edge over MAR overall, supported by stronger valuation and stronger modeled upside.
MAR
Marriott International, Inc.
MAR's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MAR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Unavailable |
MAR's profitability and cash flow are currently healthy, and its revenue is stable. There isn't enough data to rate its balance sheet.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over MAR in the historical PE scenario, which offers more potential upside but is not a forecast.
MAR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 23x | $235 | -45% |
| Fair | 31x | $306 | -28% |
| Forward | 33x | $425 | — |
| Current | 42x | $425 | — |
| Expensive | 53x | $529 | +24% |
Historical ranges are pointers, not guarantees.
MAR's PE is in its expensive range at 42x. If earnings grow as analysts expect, today's price would be 33x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
MAR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
MAR has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MAR on earnings, with more consistent year-over-year improvement.
MAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.98 | +29% |
| Q3 2026 | $10.04 | +5.9% |
| Q2 2026 | $9.67 | +8.9% |
| Q1 2026 | $9.55 | +8.6% |
| Q4 2025 | $9.51 | +14% |
| Q3 2025 | $9.48 | -0.7% |
| Q2 2025 | $8.88 | -11% |
| Q1 2025 | $8.79 | -9.2% |
| Q4 2024 | $8.33 | -18% |
MAR earned $10.04 per share over the past year, up 5.9% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MAR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
MAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7B | +8% |
| Q2 2026 | $7.1B | +4.8% |
| Q1 2026 | $6.7B | +6.2% |
| Q4 2025 | $6.7B | +4.1% |
| Q3 2025 | $6.5B | +3.7% |
| Q2 2025 | $6.7B | +4.7% |
| Q1 2025 | $6.3B | +4.8% |
| Q4 2024 | $6.4B | +5.5% |
MAR's revenue has grown year over year for 22 quarters in a row: $7B last quarter, up 8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | 0 points |
| Q2 2026 | 17% | -0.9 points |
| Q1 2026 | 16% | +0.8 points |
| Q4 2025 | 12% | -0.1 points |
| Q3 2025 | 18% | +3.1 points |
| Q2 2025 | 18% | -0.2 points |
| Q1 2025 | 15% | +0.5 points |
| Q4 2024 | 12% | -0.1 points |
MAR has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +37% |
| Q2 2026 | $796M | +63% |
| Q1 2026 | $728M | +42% |
| Q4 2025 | $657M | +$681M |
| Q3 2025 | $951M | +35% |
| Q2 2025 | $488M | -25% |
| Q1 2025 | $512M | -24% |
| Q4 2024 | -$24M | -104% |
MAR has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.3M shares |
| 1 year | -4.1% | -11.3M shares |
| 3 years | -13% | -38.9M shares |
| 5 years | -21% | -68.1M shares |
| Available history | -22% | -74.3M shares |
MAR has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.3B |
| Q2 2026 | $1.1B |
| Q1 2026 | $700M |
| Q4 2025 | $1B |
| Q3 2025 | $800M |
| Q2 2025 | $749M |
| Q1 2025 | $751M |
| Q4 2024 | $586M |
MAR spent $4.1B buying back its own shares over the past year, up 41% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MAR Net Leverage
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.9 | Overbought |
| Stochastic | 89.3 | Overbought |
MAR's weekly RSI is 73 (overbought) and its Stochastic is 89 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over MAR on valuation relative to its sector.
MAR PE vs Consumer Cyclical Sector
| Metric | MAR | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 18x | 135% above |
| PE % | 81 | 47 | 34 pts above |
MAR is trading at 42x earnings, a 135% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
MAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $387.0 | 9.7% above |
| 20 week MA | $369.3 | 15% above |
| 50 week MA | $353.3 | 20% above |
| 100 week MA | $310.1 | 37% above |
| 200 week MA | $263.5 | 61% above |
MAR is in an uptrend: it's above all five of its weekly moving averages, and 61% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
MAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $152.7 | $128.8 | -16% |
| 2021 | $128.8 | $165.2 | +28% |
| 2022 | $165.2 | $148.6 | -10% |
| 2023 | $148.6 | $225.5 | +52% |
| 2024 | $225.5 | $283.7 | +26% |
| 2025 | $283.7 | $315.6 | +11% |
| 2026 YTD | $315.6 | $424.7 | +35% |
MAR has the edge over AMZN on returns for 2026, with the stronger performance.